Please provide your email address to receive an email when new articles are posted on . Three differing doses of ISM001-055 were assessed against placebo. Each was “well-tolerated.” Each group also ...
SAN DIEGO -- Two novel drugs improved lung function in idiopathic pulmonary fibrosis (IPF) in a pair of phase IIa trials, researchers reported here. In an open-label, single-arm trial of 46 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback